Low molecular weight heparin (bemiparin sodium) and the coagulation profile of patients with heart failure.

American heart journal

Volumn 143, Issue 4, 2002, Pages 689-

  De Lorenzo, Ferruccio ^a   Newberry, Douglas ^a   Scully, Mike ^a   Kadziola, Zibgniew ^a   Dawson, Gloria ^a   Ranlall, Nancy ^a   Saba, Neelam ^a   Noorani, Ali ^a   Kashani, Shaharam ^a   Williams, Rene' ^a   Kakkar, Vijay Vir ^a  

^a THROMBOSIS RESEARCH INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BEMIPARIN; BIOLOGICAL MARKER; BLOOD CLOTTING FACTOR 7; FIBRIN DEGRADATION PRODUCT; FIBRIN FRAGMENT D; LOW MOLECULAR WEIGHT HEPARIN; PROTEIN C; THROMBIN;

AGED; ARTICLE; BLOOD; BLOOD CLOTTING DISORDER; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MALE; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BLOOD COAGULATION DISORDERS; DOUBLE-BLIND METHOD; FACTOR VII; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HEART FAILURE, CONGESTIVE; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; INJECTIONS, SUBCUTANEOUS; MALE; PROTEIN C; THROMBIN;

EID: 0036549251     PISSN: None     EISSN: 10976744     Source Type: Journal    
DOI: None     Document Type: Article

References (0)